Literature DB >> 17458534

[Botulinum toxin A injection for treatment-refractory giggle incontinence].

B Wefer1, C Seif, C van der Horst, K P Jünemann, P M Braun.   

Abstract

A 20-year-old woman reported about giggle incontinence despite antimuscarinic therapy. Therefore we injected botulinum toxin A into the detrusor muscle. The effect of botulinum toxin A appeared about 1 week after injection and no more leakage was observed even during vigorous laughter. A control uroflowmetry showed a good voiding rate without any residual volume. Botulinum toxin A might be an alternative for patients with giggle incontinence after unsuccessful antimuscarinic treatment.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17458534     DOI： 10.1007/s00120-007-1333-6

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  5 in total

Review 1.  [Botulinum toxin in urology. Indications and results].

Authors:  B Schurch; A Reitz
Journal:  Urologe A       Date:  2004-11       Impact factor: 0.639

2.  Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.

Authors:  Brigitte Schurch; Marianne de Sèze; Pierre Denys; Emmanuel Chartier-Kastler; Francois Haab; Karel Everaert; Pierre Plante; Brigitte Perrouin-Verbe; Catherine Kumar; Stephanie Fraczek; Mitchell F Brin
Journal:  J Urol       Date:  2005-07       Impact factor: 7.450

Review 3.  [Botulinum toxin in urology. An inventory].

Authors:  H Schulte-Baukloh; H H Knispel
Journal:  Urologe A       Date:  2004-08       Impact factor: 0.639

4.  Giggle incontinence in children: a manifestation of detrusor instability.

Authors:  Manju Chandra; Reeta Saharia; Qiuhu Shi; Vanessa Hill
Journal:  J Urol       Date:  2002-11       Impact factor: 7.450

5.  European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity.

Authors:  André Reitz; Manfred Stöhrer; Guus Kramer; Giulio Del Popolo; Emmanuel Chartier-Kastler; Jürgen Pannek; Harald Burgdörfer; Konrad Göcking; Helmut Madersbacher; Stefan Schumacher; Rudolf Richter; Jan von Tobel; Brigitte Schurch
Journal:  Eur Urol       Date:  2004-04       Impact factor: 20.096
  5 in total
  1 in total

1.  Can the success of structured therapy for giggle incontinence be predicted?

Authors:  Onur Telli; Nurullah Hamidi; Aytac Kayis; Evren Suer; Tarkan Soygur; Berk Burgu
Journal:  Int Braz J Urol       Date:  2016 Mar-Apr       Impact factor: 1.541
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.